Fresh analysis suggests that patients who discontinue new slimming jabs like semaglutide or tirzepatide may regain lost weight much more quickly than those who end traditional diet and exercise regimens.
Findings released in a major health publication points out that while obese individuals often shed substantial amounts of their total mass while on the medication, the mass is regained at an estimated rate of nearly a kilo each month after stopping.
"Individuals using these drugs must be cognizant of the danger of quick rebound weight gain when the medication ends," cautioned researcher Dr. Susan Jebb.
This pace of recovery suggests a reversion to pre-treatment mass within about a year and a half.
Weighing Therapies
The study, which examined 37 of trials involving thousands of participants, contrasted the outcomes of the injectable medications with other pills.
Researchers note that individuals who lose weight through lifestyle changes alone generally have a slower creep back—perhaps 0.1 kg a month—post-intervention.
The Reason for the Fast Regain
Doctors suggest the mode of action of the injections is key to understanding the accelerated regain.
GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which moderates hunger.
"Sustained high doses of the hormone levels several times higher than normal might result in the body to produce less of its own natural GLP-1, and may also reduce responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this hormone supplement results in hunger is unsuppressed, making overeating a significant risk."
An Ongoing Condition?
Health authorities recommend the injections for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
Many experts say that, given the significant potential of relapse, the treatment should be considered long-term.
This opinion is supported by drug manufacturers, who say that the results "underscore the chronic nature of obesity," comparing it to managing conditions like hypertension.
Patient Testimonies
Individuals who have come off the jabs explain a powerful resurgence of cravings.
"I experienced a trigger activating and you're instantly extremely hungry," recalled an individual.
This challenge is compounded if patients have not adopted sustainable lifestyle or habit changes during therapy.
Significant Use
Survey data show that a significant number of adults in the UK have used weight-loss jabs in the past year, with demand remaining high.
- Adoption is more common among women compared to males.
- The 40s and 50s age group shows the greatest usage rates.
- A large proportion access the drugs through private prescriptions rather than the NHS.
In conclusion, researchers emphasize that while GLP-1 drugs are effective agents for shedding pounds, they are not a standalone solution and lasting health benefits relies on ongoing behavioural management.